Evogene (EVGN.TA) gets 180-day Nasdaq extension to regain $1 bid compliance

Nasdaq granted Evogene an extra 180 days, until March 29, 2027, to regain the $1.00 minimum bid requirement, requiring a closing bid of at least $1.00 for 10 consecutive business days; failure could trigger a delisting determination.